文献速递心境障碍儿童青少年精神老年精神

心理治疗抑郁症在不同年龄段的疗效:系统综述与荟萃分析

Psychotherapy for Depression Across Different Age Groups: A Systematic Review and Meta-analysis.
PubMed 文献 · JAMA Psychiatry · 2020-01-01

该系统综述与荟萃分析纳入366项随机试验、共36 702例患者,比较心理治疗与对照条件在各年龄段的效应。总体效应量g=0.75(95%CI 0.67-0.82),儿童(g=0.35)和青少年(g=0.55)显著低于中年成人(g=0.77),年轻成人(g=0.98)显著高于中年成人,老年与高龄老年无显著差异。

要点

  • 心理治疗抑郁症总体效应量g=0.75,但异质性高(I2=80%)。
  • 儿童和青少年效应量显著低于中年成人,年轻成人效应量显著更高。
  • 中年、老年和高龄老年之间效应量无显著差异。

核心结论

  • 心理治疗对抑郁症的效应量在儿童中较小,在青少年中可能也较小,在年轻成人中可能稍大,中年、老年和高龄老年之间无 meaningful 差异。

研究设计与样本

  • 系统综述与荟萃分析,检索PubMed、PsychINFO、Embase和Cochrane数据库至2019年1月,纳入366项随机试验共36 702例患者,453个治疗与对照比较。

主要发现

  • 所有年龄段总体效应量g=0.75(95%CI 0.67-0.82),异质性很高(I2=80%;95%CI 78-82)。
  • 儿童效应量g=0.35(95%CI 0.15-0.55),青少年g=0.55(95%CI 0.34-0.75),均显著低于中年成人g=0.77(95%CI 0.67-0.87)。
  • 年轻成人效应量g=0.98(95%CI 0.79-1.16),显著大于中年成人。
  • 老年成人g=0.66(95%CI 0.51-0.82)与高龄老年g=0.97(95%CI 0.42-1.52)之间无显著差异。

关键数值与推荐

  • 主要结局为抑郁症状,效应量用Hedges g计算,随机效应模型合并,混合效应亚组分析和元回归检验年龄组差异。

临床怎么用

  • 临床中应根据年龄考虑心理治疗抑郁症的预期效应,儿童和青少年可能获益较小,年轻成人可能获益较大。

局限性

  • 多数研究质量欠佳且异质性高,结果需谨慎解读,但主要发现在敏感性分析中稳健。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: It is not clear whether psychotherapies for depression have comparable effects across the life span. Finding out is important from a clinical and scientific perspective. OBJECTIVE: To compare the effects of psychotherapies for depression between different age groups. DATA SOURCES: Four major bibliographic databases (PubMed, PsychINFO, Embase, and Cochrane) were searched for trials comparing psychotherapy with control conditions up to January 2019. STUDY SELECTION: Randomized trials comparing psychotherapies for depression with control conditions in all age groups were included. DATA EXTRACTION AND SYNTHESIS: Effect sizes (Hedges g) were calculated for all comparisons and pooled with random-effects models. Differences in effects between age groups were examined with mixed-effects subgroup analyses and in meta-regression analyses. MAIN OUTCOMES AND MEASURES: Depressive symptoms were the primary outcome. RESULTS: After removing duplicates, 16 756 records were screened and 2608 full-text articles were screened. Of these, 366 trials (36 702 patients) with 453 comparisons between a therapy and a control condition were included in the qualitative analysis, including 13 (3.6%) in children (13 years and younger), 24 (6.6%) in adolescents (≥13 to 18 years), 19 (5.2%) in young adults (≥18 to 24 years), 242 (66.1%) in middle-aged adults (≥24 to 55 years), 58 (15.8%) in older adults (≥55 to 75 years), and 10 (2.7%) in older old adults (75 years and older). The overall effect size of all comparisons across all age groups was g = 0.75 (95% CI, 0.67-0.82), with very high heterogeneity (I2 = 80%; 95% CI: 78-82). Mean effect sizes for depressive symptoms in children (g = 0.35; 95% CI, 0.15-0.55) and adolescents (g = 0.55; 95% CI, 0.34-0.75) were significantly lower than those in middle-aged adults (g = 0.77; 95% CI, 0.67-0.87). The effect sizes in young adults (g = 0.98; 95% CI, 0.79-1.16) were significantly larger than those in middle-aged adults. No significant difference was found between older adults (g = 0.66; 95% CI, 0.51-0.82) and those in older old adults (g = 0.97; 95% CI, 0.42-1.52). The outcomes should be considered with caution because of the suboptimal quality of most of the studies and the high levels of heterogeneity. However, most primary findings proved robust across sensitivity analyses, addressing risk of bias, target populations included, type of therapy, diagnosis of mood disorder, and method of data analysis. CONCLUSIONS AND RELEVANCE: Trials included in this meta-analysis reported effect sizes of psychotherapies that were smaller in children than in adults, probably also smaller in adolescents, that the effects may be somewhat larger in young adults, and without meaningful differences between middle-aged adults, older adults, and older old adults.

来源:JAMA Psychiatry,查看原文。版权归原作者所有。

引用

  1. Cuijpers P, Karyotaki E, Eckshtain D, et al. Psychotherapy for Depression Across Different Age Groups: A Systematic Review and Meta-analysis. JAMA Psychiatry. 2020. PMID: 32186668. doi:10.1001/jamapsychiatry.2020.0164

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。